On October 15, Hospira – a global specialty pharmaceutical and medication delivery company – identified its new, malignant pleural mesothelioma (MPM) treatment called Tomudex as garnering the backing of a panel of international experts. Hospira sponsored a

View full post on mesothelioma – Bing News